6 results
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
mucoadhesive buccal tablet ... chew, or crush tablet ... Prevention #Treatment #management ... opportunistic #infections #HIVAIDS ... #pharmacology
Comparison of anti-diabetic or anti-hyperglycemic agents

There are numerous anti-hyperglycemic agents available to manage Type 2 diabetes.
risks, and therapy should ... #pharmacology #pharmacotherapy ... #table #comparison ... #management #medications ... #diabetes #endocrinology
Orthopedic Dislocations (Shoulder, Elbow and Hip) - Diagnosis and Management Summary
Shoulder Dislocation
 • Fall on the
Diagnosis and Management ... rotation) • Anterior ... (most common), Anterior ... Affected hip and knee ... other end of the table
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist
Dosing:
3 mg daily x 30 days, then 7 mg
drug to remain stable ... Patients should ... been shown non-inferior ... semaglutide #Diabetes #Pharmacology ... #Endocrinology
IDSA Recommendations for Preventing and Treating Disseminated Mycobacterium Avium Complex in HIV-AIDS
Preventing 1st Episode of Disseminated
please refer to Table ... Note: Active TB should ... Prevention #Treatment #management ... opportunistic #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
empiric treatment should ... Please refer to the table ... Prevention #Treatment #management ... opportunistic #infections #HIVAIDS ... #pharmacology